Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) EPS (Basic): 2024-2025

Historic EPS (Basic) for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -$0.85.

  • Kura Oncology's EPS (Basic) fell 34.92% to -$0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.48, marking a year-over-year change of. This contributed to the annual value of -$2.02 for FY2024, which is 2.88% up from last year.
  • Latest data reveals that Kura Oncology reported EPS (Basic) of -$0.85 as of Q3 2025, which was down 13.33% from -$0.75 recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's EPS (Basic) registered a high of -$0.22 during Q4 2024, and its lowest value of -$0.85 during Q3 2025.
  • Over the past 2 years, Kura Oncology's median EPS (Basic) value was -$0.63 (recorded in 2024), while the average stood at -$0.61.
  • Data for Kura Oncology's EPS (Basic) shows a maximum YoY tumbled of 34.92% (in 2025) over the last 5 years.
  • Kura Oncology's EPS (Basic) (Quarterly) stood at -$0.22 in 2024, then plummeted by 34.92% to -$0.85 in 2025.
  • Its EPS (Basic) stands at -$0.85 for Q3 2025, versus -$0.75 for Q2 2025 and -$0.66 for Q1 2025.